Cityblock Health, Inc. announced that it will receive $399,999,253.0695 in a round of funding on September 2, 2021. The company will issue 4,121,305 series D-1 preferred shares at issue price of $78.8585 per share for the gross proceeds $324,999,930.3425 and 951,062 series D-2 preferred shares at issue price of $78.8585 per share for the gross proceeds $74,999,322.727 in the transaction. The shares are convertible, participating, non-redeemable and non-cumulative. The shares carry non-cumulative fixed dividend value of $3.9429 per annum per share. The shares will be convertible in common shares at a fixed conversion price of $78.8585 per share. The company will issue securities pursuant to exemption provided under Regulation D.